fda approves semaglutide for cardiovascular risk reduction Big news from the last week: Wegovy (semaglutide) was approved a new use, other than weight loss Rybelsus gets FDA approval to

Common side effects of glp-1 medication may include nausea, vomiting, diarrhea, and constipation

These medications support appetite regulation, but they do not replace healthy habits

Long-term use safety Traditional pain meds: Not safe for years of continuous use Require breaks or rotation Accumulating damage to organs Peptides: Can use for months to years safely BPC-157 and TB-500 have decades of use data No cumulative toxicity Actually heal tissue rather than damage it Combining peptides with pain medications Can use together: Peptides for healing NSAIDs for acute breakthrough pain Reduce medication dose as peptides work Transition plan: Start peptides while on pain meds As pain improves, reduce medication slowly Goal: Minimal or no pain meds long-term See our peptide safety and risks guide

A clinician can help you judge whether your current routine still fits your health status

Monitor your skin accordingly as everyones skin is different